Your browser doesn't support javascript.
loading
Effect of Hemoadsorption for Cytokine Removal in Pneumococcal and Meningococcal Sepsis.
Leonardis, Francesca; De Angelis, Viviana; Frisardi, Francesca; Pietrafitta, Chiara; Riva, Ivano; Valetti, Tino Martino; Broletti, Valentina; Marchesi, Gianmariano; Menato, Lorenza; Nani, Roberto; Marson, Franco; Fabbris, Mirca; Cabrini, Luca; Colombo, Sergio; Zangrillo, Alberto; Coniglio, Carlo; Gordini, Giovanni; Stalteri, Lucia; Giuliani, Giovanni; Dalmastri, Vittorio; La Manna, Gaetano.
Afiliação
  • Leonardis F; Intensive Care Unit, Fondazione Policlinico Tor Vergata, Viale Oxford 81, 00133 Roma RM, Italy.
  • De Angelis V; Intensive Care Unit, Fondazione Policlinico Tor Vergata, Viale Oxford 81, 00133 Roma RM, Italy.
  • Frisardi F; Intensive Care Unit, Fondazione Policlinico Tor Vergata, Viale Oxford 81, 00133 Roma RM, Italy.
  • Pietrafitta C; Intensive Care Unit, Fondazione Policlinico Tor Vergata, Viale Oxford 81, 00133 Roma RM, Italy.
  • Riva I; Intensive Care Unit 3, Department of Anesthesia and Intensive Care, ASST Papa Giovanni XXIII, Piazza OMS 1, 24127 Bergamo BG, Italy.
  • Valetti TM; Intensive Care Unit 3, Department of Anesthesia and Intensive Care, ASST Papa Giovanni XXIII, Piazza OMS 1, 24127 Bergamo BG, Italy.
  • Broletti V; Intensive Care Unit 3, Department of Anesthesia and Intensive Care, ASST Papa Giovanni XXIII, Piazza OMS 1, 24127 Bergamo BG, Italy.
  • Marchesi G; Intensive Care Unit 3, Department of Anesthesia and Intensive Care, ASST Papa Giovanni XXIII, Piazza OMS 1, 24127 Bergamo BG, Italy.
  • Menato L; Intensive Care Unit, Azienda ULSS 2 Marca Trevigiana, Presidio Ospedaliero di Treviso, Piazzale dell'Ospedale 1, 31100 Treviso TV, Italy.
  • Nani R; Intensive Care Unit, Azienda ULSS 2 Marca Trevigiana, Presidio Ospedaliero di Treviso, Piazzale dell'Ospedale 1, 31100 Treviso TV, Italy.
  • Marson F; Intensive Care Unit, Azienda ULSS 2 Marca Trevigiana, Presidio Ospedaliero di Treviso, Piazzale dell'Ospedale 1, 31100 Treviso TV, Italy.
  • Fabbris M; Intensive Care Unit, Azienda ULSS 2 Marca Trevigiana, Presidio Ospedaliero di Treviso, Piazzale dell'Ospedale 1, 31100 Treviso TV, Italy.
  • Cabrini L; Anesthesia and Intensive Care Unit, IRCSS San Raffaele, Via Olgettina 60, 20132 Milano MI, Italy.
  • Colombo S; Anesthesia and Intensive Care Unit, IRCSS San Raffaele, Via Olgettina 60, 20132 Milano MI, Italy.
  • Zangrillo A; Anesthesia and Intensive Care Unit, IRCSS San Raffaele, Via Olgettina 60, 20132 Milano MI, Italy.
  • Coniglio C; Resuscitation and Territorial Emergency Unit, Maggiore Hospital, Largo Nigrisoli 2, 40133 Bologna BO, Italy.
  • Gordini G; Resuscitation and Territorial Emergency Unit, Maggiore Hospital, Largo Nigrisoli 2, 40133 Bologna BO, Italy.
  • Stalteri L; Nephrology, Dialysis and Transplantation Unit, Azienda Ospedaliera-Universitaria di Bologna, Via Massarenti 9, 40138 Bologna BO, Italy.
  • Giuliani G; Nephrology, Dialysis and Transplantation Unit, Azienda Ospedaliera-Universitaria di Bologna, Via Massarenti 9, 40138 Bologna BO, Italy.
  • Dalmastri V; Nephrology, Dialysis and Transplantation Unit, Azienda Ospedaliera-Universitaria di Bologna, Via Massarenti 9, 40138 Bologna BO, Italy.
  • La Manna G; Nephrology, Dialysis and Transplantation Unit, Azienda Ospedaliera-Universitaria di Bologna, Via Massarenti 9, 40138 Bologna BO, Italy.
Case Rep Crit Care ; 2018: 1205613, 2018.
Article em En | MEDLINE | ID: mdl-30018829
Bacterial meningitis and septicemia are invasive bacterial diseases, representing a significant cause of morbidity and mortality worldwide. Both conditions are characterized by an impressive inflammatory response, resulting rapidly in cerebral edema, infarction, hydrocephalus, and septic shock with multiple organ failure. Despite advances in critical care, outcome and prognosis remain critical. Available adjunctive treatments to control the inflammatory response have shown encouraging results in the evolution of patients with sepsis and systemic inflammation, but meningococcal or pneumococcal infection has not been investigated. We herein report five patients with similar critical pathological conditions, characterized by pneumococcal or meningococcal sepsis and treated with hemoadsorption for cytokine removal. All patients showed a progressive stabilization in hemodynamics along with a rapid and marked reduction of catecholamine dosages, a stabilization in metabolic disorders, and less-than-expected loss of extremities. Therapy proved to be safe and well tolerated. From this first experience, extracorporeal cytokine removal seems to be a valid and safe therapy in the management of meningococcal and pneumococcal diseases and may contribute to the patient stabilization and prevention of severe sequelae. Further studies are required to confirm efficacy in a larger context.

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Case Rep Crit Care Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Case Rep Crit Care Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália